So what do we make of the new Flomax for stones study? This one says that there’s no difference. N is relatively small at 77. I’ve had very poor compliance with the Flomax due to cost (based on the fact that every time I write for it the pharmacy calls me and either refuses to give it to women or says the patient wants it changed to “something” else because it’s too expensive). So will you keep giving it, stop giving it or have you never started?

Abstract (http://www.annemergmed.com/article/S0196-0644(08)02183-5/abstract)

Fulltext (http://www.annemergmed.com/article/S0196-0644(08)02183-5/fulltext)